CTTP Registration

Personal Information

Language Selected

Title*

First Name*

Last Name*

Full Name*

First NameLast Name

Preferred Name:

City/Town:*

Province*

Select the institution you are part of*

Enter your selected institutional e-mail address, which will be used to access the Learning Management System (Validation)*

I do not have an institutional email address

Preferred Email Address*

This field is automatically filled upon email validation

If you selected COMMUNITY PARTNER/PATIENT/CHARITY, BIOTECH, BIOPHARMA, CRO, or OTHER above, please enter the name of the institution/organization you are part of*

If you entered COMMUNITY PARTNER/PATIENT/CHARITY, BIOTECH, BIOPHARMA, CRO, or OTHER above, please insert your preferred Email Address (validation)*

Preferred Email Address*

This field is automatically filled upon email validation

In which language do you prefer to access the courses?*

EnglishFrench

Are you an awardee?*

Yes (select 'Yes' ONLY if you are an awardee of the latest announced cycle)No

Award Year

Select your type of award

Studentship / FellowshipInternship

Award Category

Please specify the CTTP administering the award

Registration Information

Professional affiliation:*

YesNot Applicable

Please specify the type of organization (affiliation)*

Public health (authorities/systems, hospitals, research centers/institutes)Private sector (biotech, biopharma, contract research organization)Non-profit organizations/charities

Current Position (employed or volunteer, if applicable)*

Which group of CANTRAIN learners best describes you today?*

Graduate or Postdoctoral Trainee.Clinical Research Professional – e.g., Research Assistant/Associate, Coordinator, Nurse/Clinical Research Coordinator, Manager, Director etc.Trialist – Clinicians, Scientists, and Trial Methodologists.Community Partner – i.e. Patient partners, patient advocates.

Which of the following best describes your motivation to complete the CANTRAIN Common Core Foundation?*

To earn a CANTRAIN Certificate of Completion.To learn about the topic(s) covered.To engage with other learners.

How experienced are you with clinical trials?*

1

2

3

1 is I'm new to world of clinical trails, 3 is Experienced

How familiar are you with online learning?*

1

2

3

1 is Not at all!, 3 is Experienced

Quelle est votre expérience en essais cliniques?*

1

2

3

1 is I'm new to world of clinical trails, 3 is Experienced

Quelle est votre familiarité avec l'apprentissage en ligne?*

1

2

3

1 is Not at all!, 3 is Experienced

Self-Declaration

The following questionnaire was developed collaboratively by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), the Social Sciences and Humanities Research Council (SSHRC) and the Canada Foundation for Innovation (CFI). The self-identification questionnaire is a central piece of the agencies' commitment to equity, diversity and inclusion (EDI).

These data provides information on the diversity of the population applying for and receiving agency funds and increases the granting agencies' capacity to monitor their progress on increasing EDI in their programs, to recognize and remove barriers, and to design new measures to achieve greater EDI in the research enterprise. As a federally funded enterprise, CANTRAIN collects these data in order to provide aggregate reporting to the funding agencies for this purpose.

Access to these data is strictly limited to a small number of CANTRAIN staff with the appropriate training and security clearance on a need-to-know basis. Self-identification information is not part of your application and will be neither accessible to, nor shared with, other CANTRAIN staff, partners or members.

EDIA Principles

Please consult: Equity, Diversity, Inclusion and Accessibility Principles

Self Declaration

Please consult: Self-identification data collection in support of equity, diversity, and inclusion

I agree to provide my self-declaration information regarding age, sex, indigenous status, and other demographic details in an aggregated form for internal assessment and statistical purposes by the co-funders. I understand that this information will be collected anonymously and used solely for improving equity, diversity, and inclusion within our programs.

End User License Agreement (EULA)

This End User License Agreement ("Agreement" or “EULA”) is a legal contract between you ("User" or "You") and The Research Institute of the McGill University Centre through the CANTRAIN program ("Licensor", "we", or "us") governing your access to and use of the online learning and downloadable materials available through CANTRAIN’s Learning Management System ("Licensed Material").

By clicking "I Agree", you confirm that you have read, understood, and agree to be bound by the terms of this Agreement. If you do not agree, do not access or use the Licensed Material.

1. License Grant
Subject to your compliance with this Agreement, Licensor grants you a limited, non-exclusive, non-transferable, revocable license to:
- Access and view the Licensed Material solely for your personal, educational, or internal business use (“Permitted Use”);
- Where made available by Licensor, download or print a single copy of the Licensed Material for reference, provided that all copyright and proprietary notices are retained.

This license does not permit any resale, redistribution, or commercial exploitation of the Licensed Material.

2. Prohibited Uses
You agree not to:
- Share, distribute, sublicense, or otherwise make the Licensed Material available to any third party outside of a Permitted Use;
- Modify, translate, adapt, or create derivative works based on the Licensed Material;
- Use the Licensed Material in any manner that infringes any intellectual property rights or violates any applicable law;
- Use the Licensed Material in connection with any product or service that competes with Licensor’s offerings;
- Circumvent, disable, or otherwise interfere with any security features of the Licensed Material.

3. Account Security and Password Confidentiality
You are solely responsible for maintaining the confidentiality of any login credentials, including your username and password, used to access the Licensed Material. You agree not to share your password with any third party or allow any unauthorized person to access your account.

You acknowledge and agree that:
- You are fully responsible for all activities that occur under your account, whether or not authorized by you;
- Licensor shall not be liable for any loss or damage arising from your failure to protect your login credentials or from unauthorized use of your account;
- If you suspect any unauthorized access or use of your account, you must notify Licensor immediately.

Failure to comply with this section may result in suspension or termination of your access to the Licensed Material.

4. Intellectual Property Rights
All rights, title, and interest in and to the Licensed Material, including all copyrights, trademarks, and other intellectual property rights, are and shall remain the exclusive property of Licensor or its licensors. This Agreement does not grant you any ownership rights.

5. Termination
This Agreement will take effect (or re-take effect) at the moment You click “I ACCEPT” and accessing the CANTRAIN’s Learning Management System. Subject to the survival rights of certain provisions identified below, either Party may terminate this EULA as follows: Licensor may terminate this Agreement at any time without notice, and on reasonable grounds, which shall include without limitation, any reasonable belief of fraudulent or unlawful activity or actions or omissions that violate any term of this EULA. YOU may also terminate this EULA at any time by ceasing to access the CANTRAIN’s Learning Management System.

Upon termination:
- Your license to access CANTRAIN’s Learning Management System will immediately cease;
- All applicable provisions of this Agreement concerning Licensor’s proprietary rights, use of the Licensed Material, disclaimers of warranty, limitation of liability, waiver & severability, entire agreement, and governing law will survive termination of this EULA for any reason.

6. Disclaimer of Warranties
The Licensed Material is provided "AS IS" and "AS AVAILABLE" without warranties of any kind, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, accuracy, or non-infringement.

7. Limitation of Liability
To the maximum extent permitted by law, Licensor shall not be liable for any indirect, incidental, special, consequential, or punitive damages, or any loss of profits or revenues, arising out of or related to your use of or inability to use the Licensed Material.

8. Entire Agreement
This Agreement constitutes the entire agreement between You and Licensor regarding the Licensed Material and supersedes all prior or contemporaneous understandings.

Please note that Licensor reserves the right to change the terms and conditions of this EULA by posting a revised EULA or mailing and/or e-emailing notice thereof to YOU. In addition, Licensor may add, modify or delete any aspect or feature of the Licensed Material, but Licensor is not under any obligation to add any upgrade, enhancement, or modification. Your continued access and/or use of the Licensed Material following any announcement change will be conclusively deemed acceptance of the revised terms and conditions of this EULA. Accordingly, please review the terms and conditions of this EULA on a periodic basis.

9. Waiver & Severability
Failure to insist on strict performance of any of the terms and conditions of this Agreement will not operate as a waiver of any as a waiver of any such terms or conditions, and will not be construed as a waiver of any subsequent breach or default of the same or any other term or condition. No waiver shall be effective unless in writing and signed by the party against whom the waiver is to be enforced.
10. Dispute Resolution (Quebec Jurisdiction)
10.1 Private Dispute Prevention and Resolution
In accordance with the principles set out in the Code of Civil Procedure of Quebec, the parties agree to prioritize private dispute prevention and resolution processes before initiating any judicial proceedings. These processes may include negotiation, mediation, or arbitration, as mutually agreed upon by the parties.

10.2 Mandatory Mediation
Before commencing any legal action, the parties shall attempt to resolve the dispute through mediation, unless an urgent remedy is required. The mediation shall be conducted in Quebec by a mediator agreed upon by both parties. If the parties cannot agree on a mediator within fifteen (15) days, either party may request the appointment of a mediator by the Barreau du Québec or another recognized body.

10.3 Jurisdiction and Venue
If the dispute cannot be resolved through mediation, the parties agree that any legal proceedings shall be brought exclusively before the competent courts of the Province of Quebec, judicial district of Montreal, and shall be governed by the laws of Quebec, including the Code of Civil Procedure.

10.4 Costs
Each party shall bear its own costs related to dispute resolution, including mediation and legal fees, unless otherwise determined by the court or agreed upon in writing.

By clicking "I Agree", you acknowledge that you have read, understood, and agree to be bound by the terms of this Agreement.

I agree

Consent & Signature

Disclaimer

The recommendations, and e-learning and e-training resources found within the CANTRAIN website and learning management system for Clinical Trials Training are intended to inform and instruct various streams of learners and other stakeholders who are interested or deliver services related to the conduct of clinical trials.

The best available and relevant evidence and science have informed the content of these courses.

Patient, parents, and/or caregivers may wish to bring their healthcare and other providers’ attention to these resources when considering enrolling in clinical trials. Healthcare professionals should also consider their own judgment, and the preferences of their patients, in their decisions relating to the conduct of clinical trials.

The CANTRAIN project team, designers, developers, contributors, mentors, subject / content matter experts and supporting partners shall not be liable for any damages, claims, liabilities, costs, or obligations arising from the use or misuse of these courses including loss or damage arising from any claims made by a third party.

Any citations or changes must be accompanied by the statement: “Adapted from CANTRAIN curriculum with/ without permission,” according to whether or not permission was sought and/or given.

Signature*

Date*

Date

Please verify that you are human*